College of Life Sciences, Shenyang Normal University, Shenyang, 110034, Liaoning, China.
3 developments in the corpus
Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
Rigorous population-level analysis using GBD 2021 data with quantified trends, sex-stratified findings, and validated projection methodology, demonstrating a major epidemiological shift in liver cancer etiology in China with clear effect sizes and uncertainty intervals.
A single-arm, algorithm development study on benchmark datasets with no clinical validation, control group comparison, or patient outcome data; demonstrates technical feasibility but not clinical utility or safety.
A comprehensive narrative review synthesizing advances in eukaryotic cell-free protein synthesis technology, chassis diversity, and engineering strategies—informative for researchers and practitioners but not reporting primary experimental data or comparative trials.